{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:43:14Z","timestamp":1780447394859,"version":"3.54.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,5,31]],"date-time":"2006-05-31T00:00:00Z","timestamp":1149033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,5,31]],"date-time":"2006-05-31T00:00:00Z","timestamp":1149033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s10067-006-0325-z","type":"journal-article","created":{"date-parts":[[2006,5,30]],"date-time":"2006-05-30T19:16:50Z","timestamp":1149016610000},"page":"1186-1188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Treatment of early and refractory dermatomyositis with infliximab: a report of two cases"],"prefix":"10.1007","volume":"26","author":[{"given":"Sylvia","family":"Dold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Justiniano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis R.","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,5,31]]},"reference":[{"key":"325_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292:344\u2013347, 403\u2013407","journal-title":"N Engl J Med"},{"key":"325_CR2","first-page":"2230","volume":"28","author":"I Marie","year":"2001","unstructured":"Marie I, Hachulla E, Hatran PY et al (2001) Polymyositis and dermatomyositis: short term and long term outcome, and predictive factors of prognosis. J Rheumatol 28:2230\u20132237","journal-title":"J Rheumatol"},{"key":"325_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s10067-005-1164-z","volume":"25","author":"A Airio","year":"2006","unstructured":"Airio A, Kautiainen H, Hakala M (2006) Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol 25:234\u2013239","journal-title":"Clin Rheumatol"},{"key":"325_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/rheumatology\/41.1.7","volume":"41","author":"EH Choy","year":"2002","unstructured":"Choy EH, Isenberg DA (2002) Treatment of dermatomyositis and polymyositis. Rheumatology (Oxford) 41:7\u201313","journal-title":"Rheumatology (Oxford)"},{"key":"325_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10067-004-1061-x","volume":"24","author":"SK Agarwal","year":"2005","unstructured":"Agarwal SK, Monach PA, Docken WP, Coblyn JS (2005) Characterization of relapses in adult idiopathic inflammatory myopathies. Clin Rheumatol 24:1\u20136","journal-title":"Clin Rheumatol"},{"key":"325_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/08916930500124023","volume":"38","author":"K Takada","year":"2005","unstructured":"Takada K, Nagasaka K, Miyasaka N (2005) Polymyositis\/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants. Autoimmunity 38:383\u2013392","journal-title":"Autoimmunity"},{"key":"325_CR7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/art.20849","volume":"52","author":"TD Levine","year":"2005","unstructured":"Levine TD (2005) Rituximab in the treatment of dermatomyositis: an open label study. Arthritis Rheum 52:601\u2013607","journal-title":"Arthritis Rheum"},{"key":"325_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/archderm.142.1.65","volume":"142","author":"JC Edge","year":"2006","unstructured":"Edge JC, Outland JD, Dempsey JR, Callen JP (2006) Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis. Arch Dermatol 142:65\u201369","journal-title":"Arch Dermatol"},{"key":"325_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10067-005-1109-6","volume":"24","author":"K Oryoji","year":"2005","unstructured":"Oryoji K, Himaji D, Nagafuji K et al (2005) Successful treatment of rapidly progressive interstitial pneumonia with autologous peripheral blood stem cell transplantation in a patient with dermatomyositis. Clin Rheumatol 24:637\u2013640","journal-title":"Clin Rheumatol"},{"key":"325_CR10","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/rheumatology\/keh226","volume":"43","author":"C Korkmaz","year":"2004","unstructured":"Korkmaz C, Tamiz C, Cetinbas F, Buyukkidan B (2004) Successful treatment of alveolar hypoventilation due to dermatomyositis with anti-tumor necrosis factor-alpha. Rheumatology (Oxford) 43:937\u2013938","journal-title":"Rheumatology (Oxford)"},{"key":"325_CR11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/rheumatology\/keh539","volume":"44","author":"A Anandacoomarasamy","year":"2005","unstructured":"Anandacoomarasamy A, Howe G, Manolios N (2005) Advanced refractory polymyositis responding to infliximab. Rheumatology 44:562\u2013563","journal-title":"Rheumatology"},{"issue":"Suppl 2","key":"325_CR12","doi-asserted-by":"publisher","first-page":"ii79","DOI":"10.1136\/ard.2004.028498","volume":"63","author":"EC Keystone","year":"2004","unstructured":"Keystone EC (2004) The utility of tumor necrosis factor blockade in orphan diseases. Ann Rheum Dis 63(Suppl 2):ii79\u2013ii83","journal-title":"Ann Rheum Dis"},{"key":"325_CR13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s004010051165","volume":"99","author":"S Kuru","year":"2000","unstructured":"Kuru S, Inukai A, Liang Y, Doyu M, Takano A, Sobue G (2000) Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis. Acta Neuropathol 99:585\u2013588","journal-title":"Acta Neuropathol"},{"key":"325_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s100670070027","volume":"19","author":"T Shimizu","year":"2000","unstructured":"Shimizu T, Tomita Y, Son K, Nishinarita S, Sawada S, Horie T (2000) Elevation of serum soluble tumor necrosis factor receptor in patients with polymyositis and dermatomyositis. Clin Rheumatol 19:352\u2013359","journal-title":"Clin Rheumatol"},{"key":"325_CR15","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8","volume":"43","author":"LM Pachman","year":"2000","unstructured":"Pachman LM, Liotta-Davis MR, Hong DK et al (2000) TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. Arthritis Rheum 43:2368\u20132377","journal-title":"Arthritis Rheum"},{"key":"325_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000070852","volume":"50","author":"GJD Hengstman","year":"2003","unstructured":"Hengstman GJD, van den Hoogen FHJ, Barrera P, Netea MG, Pieterse A, van den Pute LBA et al (2003) Successful treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: Preliminary observations. Eur Neurol 50:10\u201315","journal-title":"Eur Neurol"},{"key":"325_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000079547","volume":"52","author":"GJD Hengstman","year":"2004","unstructured":"Hengstman GJD, van den Hoogen FHJ, van Engelen BGM (2004) Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: long-term follow-up. Eur Neurol 52:61\u201363","journal-title":"Eur Neurol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0325-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-006-0325-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0325-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0325-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T16:57:27Z","timestamp":1652806647000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-006-0325-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,31]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1007\/s10067-006-0325-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,31]]},"assertion":[{"value":"9 April 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}